Genentech - GS39684
Laufzeit: 01.01.2017 - 31.12.2018
imported
Kurzfassung
A PHASE IIa, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY OF GDC-0853 IN PATIENTS WITH REFRACTORY CHRONIC SPONTANEOUS URTICARIA (CSU)
